Cited by 38Dialysis and Renal Disease ManagementAdvanced Glycation End Products researchChronic Kidney Disease and Diabetes

Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker

Copur, Sidar, Siriopol, Dimitrie, Afsar, Baris, Comert, Melis C., Uzunkopru, Gizem, Sag, Alan A., Ortiz, Alberto, Covic, Adrian +4 more·2021·Acta Diabetologica

Abstract

Background and aim HbA1c, the traditional and current gold standard biomarker guiding diabetic management, has been scrutinized for low predictive value for patients with chronic kidney disease due to variables affecting erythrocyte number and turnover. Glycated albumin, the precursor to advanced glycation end products, reflects glycemic status over the preceding 2-3 week period and already outperforms HbA1c for glycemic monitoring. Our aim was to establish whether serum GA can be further used to predict mortality risk in dialysis patients with diabetes mellitus (DM) METHODS: We did systematic review of the literature in PubMed/Medline, Web of Science, Embase (Elsevier) and the Cochrane Central Register of Controlled Trials (Wiley) up to and including February 2020. Results This meta-analysis included 25,932 dialysis patients across 12 studies with maximum follow-up of 11 years. Higher GA levels were associated with the risk of all-cause mortality in dialysis patients with DM (HR 1.02, 95% CI 1.01 to 1.03, P Conclusion Serum glycated albumin predicts all-cause mortality risk in dialysis patients with DM. The endpoints of cardiovascular mortality and cardiovascular events trended similarly, but did not reach significance at the current sample size.

Integrity signals

Registry

Crossref · 10.1007/s00592-020-01581-x

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Glycated albumin and fructosamine, which reflect average glycemia over a shorter time (15-30 days), are helpful in clinical management.

    “Therefore, glycated albumin and fructosamine, which reflect average glycemia over a shorter time (15-30 days), are helpful in clinical management (65,66).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Copur, S., Siriopol, D., Afsar, B., Comert, M. C., Uzunkopru, G., Sag, A. A., Ortiz, A., Covic, A., van Raalte, D. H., Cherney, D. Z., Rossing, P., & Kanbay, M.
Affiliations
  • Grigore T. Popa University of Medicine and Pharmacy (RO)
  • Koç University (TR)
  • Duke Medical Center (US)
  • University Health Network (CA)
  • University of Copenhagen (DK)
Corresponding author
Kanbay, Mehmet
Venue
Acta Diabetologica
Published
2020-08-30
Volume
58
Issue
1
Pages
81-91
ISSN
  • 0940-5429 (ISSN-L)
  • 1432-5233
OpenAlex
W3082094221
Cited by
38
References
51
Citations by year
2026: 1 · 2025: 8 · 2024: 4 · 2023: 4 · 2022: 7 · 2021: 13 · 2020: 1
FWCI
1.01
Type
journal article
Language
en
Open access
closed
Locations
  • Acta Diabetologica (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
Steno Diabetes Center Copenhagen (SDCC 3.A Complications)
Topics
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords
glycated albumin, all-cause mortality, dialysis patients, diabetes mellitus, mortality prediction, HbA1c, cardiovascular mortality, cardiovascular events, chronic kidney disease, advanced glycation end products, blood glucose monitoring
MeSH terms
Glycated Serum Albumin, Aged, Aged, 80 and over, Blood Glucose, Cause of Death, Diabetes Mellitus, Diabetic Angiopathies, Diabetic Nephropathies, Female, Renal Dialysis, Glycated Hemoglobin, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Serum Albumin, Biomarkers, Glycation End Products, Advanced, Renal Insufficiency, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review